Synthetic procedures
The following compounds were prepared according to literature procedures. [1] ((2s,3aR,9aS,E)-3a,4,5,8,9,9a-hexahydrocycloocta[d][1,3]dioxol-2-yl)methanol [2] (rel-1R,8S,9R,4E)-Bicyclo[6.1.0]non-4-ene-9-yl-methanol [3] 4-methoxyphenylglyoxal [4] S3 2-oxo-2-(4-methoxyphenyl)acetaldehyde oxime [5] To a solution of 4-methoxyphenylglyoxal (1.73 g, 10.5 mmol) in EtOH (25 mL) H 2 O (10 mL), hydroxylamine hydrochloride (879 mg, 12.6 mmol) and anhydrous sodium carbonate (670 mg, 6.32 mmol) were added at 0 °C. After one hour at room temperature the mixture was diluted with brine (50 mL) and then extracted with EtOAc (2x 100 mL). The combined organic layers were washed with sat. aq. NaHCO 3 (70 mL), dried over Na 2 SO 4 and concentrated in vacuo. The crude oxime (1.63 g) was used directly in the next step without further purification. [6] To a solution of 2-oxo-2-(4-methoxyphenyl)acetaldehyde oxime (1.63 g, 9.10 mmol) in EtOH (25 mL) hydrazine monohydrate (758 µL, 10.0 mmol) and a few drops of acetic acid were added at 45 °C. The solution was stirred at 45 °C for 15 h. After the starting material has disappeared, the crude product was concentrated in vacuo and purified by flash column chromatography (eluting with 0-25% EtOAc in CH 2 Cl 2 + 1% MeOH) to provide the oximinohydrazone as an orange solid (1.02 mg, 58%). The identity of the purified product was verified by HPLC-MS on a Luna® C18 column (3u, 100A, 100 x 4.6 mm) using a linear gradient of CH 3 CN (5-95% in 9 min and 1mL/min flow) in H 2 O + 0.05% HCOOH. The purification provided two isomers of the oximinohydrazone eluting at 6.42 min and 8.06 min, respectively ( Figure S1 ). MS (ESI): m/z calcd. for C 9 H 12 N 3 O 2 [MH] + 194.1, found 194.1. Figure S1 . HPLC-MS analysis of the two isomers of 2-hydrazono-2-(4-methoxyphenyl)acetaldehyde oxime obtained after purification by flash column chromatography. [6] 2-Isonitrosoacetophenone (2.50 g, 16.8 mmol) and a few drops of acetic acid were added to a solution of hydrazine monohydrate (1.27 mL, 16.8 mmol) in EtOH (25 mL) at 45 °C. The mixture was stirred at 45 °C for 20 h. After the starting material has disappeared, the crude product was concentrated in vacuo and purified by flash column chromatography (eluting with 0-20% EtOAc in CH 2 Cl 2 + 1% MeOH) to provide the oximinohydrazone as a yellow solid (2.26 g, 82%). Analytical data matched with literature. [7] 3-(2-pyridyl)-6-phenyl-1,2,4-triazine (1) [6] To a solution of 2-hydrazono-2-phenylacetaldehyde oxime (167 mg, 1.02 mmol) in EtOH (7 mL) a few drops of acetic acid and 2-pyridinecarboxaldehyde (117 µL, 1.23 mmol) were added. The solution was stirred at room temperature for 21 h. The formed bisaryl substituted intermediate was concentrated in vacuo, dissolved in acetic acid (2 mL) and heated at 100 °C under reflux for 1 h. After the complete intermediate was cyclized (verified by HPLC-MS),
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the mixture was concentrated in vacuo, diluted with H 2 O (10 mL) and the pH was adjusted to ~8 by addition of sat. aq. NaHCO 3 . The suspension was extracted with CH 2 Cl 2 (3x 60 mL) and the combined organic layers were washed with brine (70 mL), dried over Na 2 SO 4 and concentrated in vacuo. The crude triazine was purified by flash column chromatography (eluting with 0-30% MeOH in CH 2 Cl 2 ) and further by recrystallization from EtOAc to provide 1 as a light-brown solid (154 mg, 64% [6] 3-(2-pyridyl)-6-(4-methoxyphenyl)-1,2,4-triazine (2) [6] A few drops of acetic acid and 2-pyridinecarboxaldehyde (292 µL, 3.07 mmol) were added to a solution of 2-hydrazono-2-(4-methoxyphenyl)acetaldehyde oxime (362 mg, 1.87 mmol) in EtOH (10 mL 
3-(4-pyridyl)-6-(4-methoxyphenyl)-1,2,4-triazine (3)
To a solution of 2-hydrazono-2-(4-methoxyphenyl)acetaldehyde oxime (420 mg, 2.17 mmol) in EtOH (15 mL) were added a few drops of acetic acid and 4-pyridinecarboxaldehyde (205 µL, 2.17 mmol). The solution was stirred at room temperature for 28 h. The formed bisaryl substituted intermediate was concentrated in vacuo, dissolved in acetic acid (6 mL) and heated at 100 °C under reflux for 1 h. After the complete intermediate was cyclized (verified by HPLC-MS), the mixture was concentrated in vacuo, diluted with H 2 O (10 mL) and the pH was adjusted to ~8 by addition of sat. aq. NaHCO 3 . The suspension was extracted with CH 2 Cl 2 (3x 60 mL) and the combined organic layers were washed with brine (70 mL), dried over Na 2 SO 4 and concentrated in vacuo. The crude triazine was purified by flash column chromatography (eluting with 0-65% EtOAc in CH 2 Cl 2 + 1% MeOH) to provide 3 as a yellow solid (316 mg, 55%). 2-formyl-1-methylpyridinium iodide [8] 4-formyl-1-methylpyridinium iodide [8] 1-methyl-2-(6-phenyl-1,2,4-triazin-3-yl)pyridinium iodide (4) 3-amino-6-bromo-1,2,4-triazine 3-amino-6-bromo-1,2,4-triazine was prepared according to a slightly modified literature procedure with an additional purification step by flash column chromatography (eluting with 0-90% EtOAc in CH 2 Cl 2 + 1% MeOH) at the end.
[9]
Analytical data matched with literature.
[10]
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6-(4-nitrophenyl)-1,2,4-triazine (8)
6-(4-nitrophenyl)-1,2,4-triazine was prepared according to a slightly modified literature procedure. [10] Following the literature procedure, conditions of the Suzuki coupling were modified as follows: the reaction was performed in DMF/H 2 O (4:1) mixture and K 2 CO 3 was used as base instead of Cs 2 CO 3 . Analytical data matched with literature. [10] 6-(4-pyridyl)-1,2,4-triazine (7)
Following the literature procedure, [10] 3-amino-6-bromo-1,2,4-triazine (500 mg, 2.86 mmol), 
1-(2-carboxyethyl)-4-(6-(4-methoxyphenyl)-1,2,4-triazin-3-yl)pyridinium formate (9)
To a suspension of 3 (50 mg, 0.19 mmol) in 2-butanone (2.5 mL) was added 3-iodo-propionic acid (189 mg, 0.95 mmol, 5 eq.) and the reaction mixture was stirred at 80 °C overnight. The solvent was removed in vacuo and the product was isolated by normal phase silica gel column chromatography (eluting with CH 3 CN/H 2 O (4:1) → CH 3 CN/H 2 O (4:1) + 0.25% HCOOH). The product was isolated as yellow powder and as salt of formic acid (51 mg, 71% 
1-(3-hydroxypropyl)-4-(6-(4-methoxyphenyl)-1,2,4-triazin-3-yl)pyridinium chloride (10)
To a suspension of 3 (25 mg, 0.095 mmol) in 2-butanone (1 mL) was added 4-iodo-propanol (45 µL, 0.47 mmol, 5 eq.) and the reaction mixture was stirred at 100 °C for 1 h and then at 80 °C overnight. The solvent was removed under vacuum and the product was isolated by normal phase silica gel column chromatography (eluting with CH 3 CN/H 2 O (10:1) + 0.1% of sat. aq. NH 4 PF 6 ). Fractions containing the product were collected, evaporated and the solid was transferred into 2 mL polypropylene tube. The solid was repeatedly washed with H 2 O (3x 1mL) to remove excess of NH 4 PF 6 . After each washing step the tube was centrifuged and the liquid discarded. This product (as PF 6 -salt) was further purified by second silica gel column (eluting with DCM/MeOH = 9:1). The product was isolated as a yellow powder (33 mg, 75%). The 
4-(6-(4-methoxyphenyl)-1,2,4-triazin-3-yl)-1-(pent-4-yn-1-yl)pyridinium iodide (11)
To a Schlenk tube containing a solution of triazine 3 (50 mg, 0.189 mmol) in anhydrous DMF (4 mL) was added step by step over several hours 5-iodo-1-pentyne (312 mg, 1.61 mmol) until the starting material has disappeared (verified by HPLC-MS). The reaction was performed under argon and at 50 °C. The crude product was concentrated in vacuo and purified by silica gel column chromatography (eluting with CH 2 Cl 2 /MeOH (20:1) → (10:1) → (5:1)) to provide the alkylated triazine 11 as an orange solid (58 mg, 67%). 
1-azido-3-iodopropane
1-azido-3-iodopropane was prepared according to a slightly modified literature procedure. [11] Following the literature procedure, the crude product was purified by silica gel column chromatography (eluting with petroleum ether/EtOAc (4:1)) instead of distillation under reduced pressure. Analytical data matched with literature.
[11]
1-(3-azidopropyl)-4-(6-(4-methoxyphenyl)-1,2,4-triazin-3-yl)pyridinium iodide (12)
To a Schlenk tube containing a solution of triazine 3 (50 mg, 0.189 mmol) in anhydrous DMF (4 mL) was added 1-azido-3-iodopropane (200 mg, 0.946 mmol). The tube was flushed with argon and heated at 50 °C for 77 h. The crude product was concentrated in vacuo and purified by flash column chromatography (eluting with 0-10% MeOH in CH 2 Cl 2 ) to provide the alkylated triazine 12 as an orange brown solid (75 mg, 83% 
Synthesis of compound 13
To an ice-water bath cooled suspension of 9 (10 mg, 0.026 mmol) in dry DMF (0.5 mL) was added N-Boc-4,7,10-trioxa-1,13-tridecanediamine (12.5 mg, 1.5 eq.) under argon followed by solid HATU (11 mg, 1.2 eq.) and DIPEA (11 µL, 2.5 eq.). The reaction mixture was stirred at room temperature under argon overnight. DMF was removed under vacuum and the residue S11 was purified by silica gel column chromatography (eluting with DCM/MeOH (9:1) → (5:1)). The product was isolated as yellow viscous oil (10 mg, 56% 
Synthesis of compound 14
To an ice-cold solution of 10 (as PF 6 -salt, 15 mg, 0.032 mmol) in dry DMF (1 mL) was added solid disuccinimidyl carbonate (DSC, 16.4 mg, 2 eq.) under argon followed by Et 3 N (18 µL, 4 eq.). The reaction mixture was stirred at room temperature until starting material disappeared (3 h, TLC in DCM/MeOH (9:1) and/or HPLC-MS). Our attempts to isolate the active ester by column chromatography led to partial decomposition of the product back to the starting material. However, the crude reaction mixture could be used directly in the next reaction step. The yield was ca. 80% (based on integrated peak area, Figure S3 ). 
Synthesis of compound 15
2-(2-(2-(2-azidoethoxy)ethoxy)ethoxy)ethan-1-ol (6 mg, 2.5 eq.) was added to a suspension of 11 (5 mg, 0.011 mmol) in H 2 O/DMSO (3:2) (300 µL). In a separate tube aqueous Naascorbate solution (0.43 mg in 5 µL of H 2 O, 20 mol%,) was added to a mixture of Cu-ligand BTTP [12] (1 mg, 20 mol%) and CuSO 4 .5 H 2 O (0.3 mg, 10 mol%) in 10 µL of H 2 O/DMSO
(1:1). The colorless activated solution of the catalyst was added to the suspension of the alkyne and azide reagents and the reaction mixture was stirred at room temperature. The progress of the reaction was followed by HPLC-MS. After 2.5 h the reaction mixture did not change any longer giving 76% of the product (based on integrated peak area, Figure S4 ). 95% B in 9 min, then 2 min 95% B and back to 5% B). Starting alkyne eluates at 6.9 min and the product 15 at 6.5 min (Luna® C18 column, 3u, 100A, 100 x 4.6 mm, 1 mL/min flow rate).
Determination of the second-order rate constants
Second order rate constants of the reactions between triazines and trans-cyclooctenes (TCO) were determined by following the decrease in the concentration of the starting 1,2,4-triazine over time. The concentration decrease was monitored either by HPLC (for slower derivatives) or by UV/VIS spectroscopy (for faster derivatives). The measurements were performed in a mixture of CH 3 CN/H 2 O (1:1) at room temperature under pseudo first-order conditions using an excess of the corresponding TCO. All runs were conducted at least three times. concentration of all triazines was 2 mM using 10 eq. of TCO (1 mM of triazine using 9 eq. of TCO for 6 + TCO-ol and 0.5 mM of triazine using 10 eq. of TCO for 4 + d-TCO). The measurements were performed on a Luna® C18 column (3u, 100A, 100 x 4.6 mm) using a linear gradient of CH 3 CN + 0.05% HCOOH in H 2 O + 0.05% HCOOH (5→95% in 9 min) at a flow rate of 1.0 mL/min. The MS device was disconnected from the HPLC during measurements. The integral of the absorption of the triazine at 254 nm was measured over 105 or 360 min in 15 or 45 min intervals. By using a calibration curve, the measured integrals were converted into the corresponding concentrations of the triazine, which were plotted against time to provide the observed rate constant from the slope of this plot (fitted with single exponential function: y = y 0 + Ae -k/t ). 1) to a give a final volume of 3 mL and immediately measured on the UV/VIS spectrophotometer. The final concentration of all triazines was either 45 µM or 50 µM using either 5 eq. or 10 eq. of TCO. The decrease in the absorption of the triazine was followed over 5-120 min in intervals of 0.25, 0.5, 1, 2 or 5 min. The time-dependent measurements were performed at the corresponding absorption maxima of the triazine used, which was determined by UV/VIS spectroscopy before the measurement. The measured intensity of the absorption was plotted against time. Fitting the curves with single exponential equation (y = y 0 + Ae -k/t ) provided the observed rate constants. The second order rate constants were calculated by dividing the observed rate constants with initial concentration of the TCO. All data were processed using Origin or Excel software and are summarized in table S2.
Calculated and found low-resolution masses of the click-products from rate studies.
The following experiments were performed to verify the formation of the corresponding click products during kinetic studies. 30 µL of a 10 mM solution of triazine in CH 3 CN/H 2 O (1:1) were added to 15 µL of a 25 mM solution of the appropriate TCO in CH 3 CN/H 2 O (1:1). The mixture was diluted with CH 3 CN/H 2 O (1:1) to a final volume of 150 µL. The final concentration of all triazines was 1 mM using 1.25 eq. of TCO. The solution was incubated at room temperature for 30 min and then measured by HPLC-MS on a Luna® C18 column (3u, 100A, 100 x 4.6 mm) using a linear gradient of CH 3 CN + 0.05% HCOOH (5→95% in 9 min) in H 2 O + 0.05% HCOOH at a flow rate of 1.0 mL/min. During the kinetic measurement we have observed in some cases also the formation of the corresponding oxidized pyridine products together with the dihydropyridine product. These particular cases are indicated in Table S1 . a) for these compounds the mass of the oxidized form of the click-product was found as well, b) for this compound only the mass of the oxidized form of click-product was found. 
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Stability studies of compound 6
The stability studies for triazine 6 were performed in CH 3 CN/PBS (1:2) in the absence as well as in the presence of L-cysteine and were monitored by HPLC-MS on a Luna® C18 column (3u, 100A, 100 x 4.6 mm) (solvent A: H 2 O + 0.05% HCOOH; solvent B: CH 3 CN + 0.05% HCOOH; gradient: 5% B → 95% B in 9 min, then 2 min 95% B and back to 5% B; flow rate: 1.0 mL/min). For the stability study without L-cysteine, 0.4 mL of a 15 mM solution of triazine 6 in CH 3 CN/PBS (1:1) were diluted with PBS to a final volume of 0.6 mL. For the stability study with L-cysteine, 0.2 mL of a 30 mM solution of L-cysteine in PBS were added to 0.4 mL of a 15 mM solution of triazine 6 in CH 3 CN/PBS (1:1). The final concentration of all reactants in both studies was 10 mM. In both cases the samples were incubated at 37 °C for 209 h and measured several times on the HPLC-MS ( Figure S5 and S6) . Figure S8 ).
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All HPLC-MS measurements were performed on a Luna® C18 column (3u, 100A, 100 x 4.6 mm) using a linear gradient of CH 3 CN + 0.05% HCOOH (5→95% in 9 min) in H 2 O + 0.05% HCOOH at a flow rate of 1.0 mL/min.
Scheme S1. Sequential double click-labeling of 12 using d-TCO and subsequently BCN. 
Synthesis and characterization of the click product 17
Scheme S4. Reaction scheme for the preparation of 17.
Solution of d-TCO (5.10 mg, 0.0277 mmol) dissolved in CD 3 CN/D 2 O (1:1) (500 µL) was added to Triazine 6 (7.5 mg, 0.0185 mmol) dissolved in CD 3 CN/D 2 O (1:1) (500 µL). The mixture was stirred under argon at room temperature for 1 h. Formation of the click product 17 was verified by HPLC-MS and the crude reaction mixture was directly used for characterization by NMR ( Figure S11 and S12). 17 is formed as a mixture of diastereomers (4 in total). Two major diastereomers were assigned based on ROESY experiment. The two minor diastereomers are formed from the anti d-TCO isomer (starting d-TCO was used as an inseparable mixture of syn/anti = 12:1). 
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Formation of the oxidized product 17ox during preparative TLC Our attempt to purify the click product 17 by preparative TLC (eluting with CH 3 CN/H 2 O (4:1) and washing the silica with CH 3 CN/H 2 O (4:1) + 0.5% HCOOH led to isolation of the corresponding oxidation click product 17ox. The identity of the oxidized product was confirmed by HPLC-MS ( Figure S13 ) and NMR. 
Stability of the click product 17
The stability studies of the click product 17 were performed in CH 3 CN/H 2 O (1:1) at room temperature under exposure to air and were monitored by HPLC-MS on a Luna® C18 column (3u, 100A, 100 x 4.6 mm) using a linear gradient of CH 3 CN + 0.05% HCOOH (5→95% in 9 min) in H 2 O + 0.05% HCOOH at a flow rate of 1.0 mL/min. 0.5 mL of a 10 mM solution of 6 in CH 3 CN/H 2 O (1:1) were added to 0.3 mL of a 25 mM solution of d-TCO in CH 3 CN/H 2 O (1:1). The mixture was diluted with CH 3 CN/H 2 O (1:1) to a final volume of 1 mL in order to get 5 mM final concentration of 6 using 1.5 eq of d-TCO. The solution was stirred at room temperature until starting material has disappeared (5 h, monitored by HPLC-MS, indicated time 0 min in Figure S13 ). For stability study, the clickproduct 17 was stirred at room temperature for 97 h in total under exposure to air. During that time the reaction mixture was measured several times by HPLC-MS ( Figure S14 ). 
Photophysical properties of the click product 17
A freshly prepared solution of 17 was used in the following experiments. Conditions: To 50 µL of a solution of 6 in CH 3 CN/H 2 O (1:1) (stock: 50 mM) were added 50 µL of d-TCO solution in CH 3 CN/H 2 O (1:1) (stock: 100 mM, 2 equiv.) giving a 25 mM final concentration of 6 and 17 respectively. The reaction mixture was incubated at room temperature in the dark for 0.5 h and then analyzed by HPLC-MS to verify the formation of the click product ( Figure  S15 ). This solution was further diluted in different solvents and used as such for absorbance measurements the quantum yield determination measurements ( Figure S16-S18) . Quantum yield of the click product 17 in different solvents was measured at 22°C in 1 cm quartz cuvette using 5µM final concentration of 17. The experiment was performed on FluoroMax 4 spectrofluorometer (Jobin Yvon, Horiba) equipped with a 450 W xenon lamp using Rhodamine 6G (solution in EtOH) as reference (ɸ QS = 0.94). The settings were as follows: Excitation wavelength 405 nm, slit 5.0 nm; Emission 500 -750 nm, increment 1.0 nm, slit 5.0 nm and data algebra formula S1c/R1c. The fluorescence quantum yields were calculated using the following equation:
Where: ɸ ref is 0,94 (Quantum yield of Rhodamine 6G in EtOH) [13] F are the integrated intensities (areas) of standard and the sample fluorescence spectra (integrals calculated using OriginPro software) abs is the absorbance of standard and sample at the excitation wavelength (405 nm) 
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Cell labeling experiments
U2OS cells were maintained in high glucose DMEM (Sigma) supplemented with 10% FBS (Biosera) and antibiotics at 37 °C/5% CO 2 . One day before experiment cells were seeded at density 0.3x10 6 at the glass bottom dishes (SPL Life Sciences 3.5 cm diameter). Triazine 6 was dissolved in DMSO/H 2 O = 1/1 (5 mM) and further diluted before experiments. d-TCO stock solution was in DMSO (50 mM). Images were acquired on Zeiss LSM 780 or Leica TCS SP5 confocal scanning microscopes and raw pictures were processed by FIJI software. [14] Excitation: 405nm, emission window: 525-648 nm for click products). The nucleus was stained with DRAQ5 (excitation: 633 nm, emission window: 667-748 nm).
Mitochondria labeling in live U2OS cells
U2OS Cells were incubated with 5 µM (final) concentration of 6 in complete media for 3 h/37 °C. Cells were washed once with the media, and incubated for further 30 min in complete DMEM medium without phenol red containing 500 nM DRAQ5 dye (Thermo Fisher). The cells were then incubated with d-TCO (25 µM final concentration) for 15 min at 37 °C prior to imaging ( Figure S19 ). Laser intensity was set up to 10%. 
Preparation of concanavalin A d-TCO conjugate (ConA-dTCO)
2.5 mg of Concanavalin A (Sigma #C2010) were dissolved in 1 ml of 150 mM NaCl, 50 mM HEPES pH 8.3 (to obtain a 2.5 mg/ml solution). 250 µL (0.625 mg) of this solution were combined with 3.6 µL of 100 mM d-TCO NHS active ester (10x molar excess dissolved in dry DMSO). The reaction mixture was incubated at room temperature for one hour with constant shaking. After one hour precipitated material was spun at 25000 rpm for 10 min. Clean supernatant was split and 2x 130 µL was loaded onto two Zeba desalting columns preconditioned with 150 mM NaCl, 50 mM TRIS pH 7.4 (in total 2 columns were used). Note: The d-TCO active ester partially precipitated when added to ConA but after one hour the solution became clear again.
ConA-dTCO Experiment 1 on live cells
Live U2OS cells were incubated for 10 min with ConA-dTCO (100x diluted) Figure S21 ). Figure S21 . U2OS live cell labeling experiment using ConA-dTCO conjugate and triazine 6. Only weak signal has been observed when the experiment was performed on live cells.
ConA-dTCO Experiment 2
Live U2OS cells were incubated for 10 min with ConA-dTCO (100x diluted) in Dulbeccos PBS (DPBS, with Ca 2+ and Mg 2+ ). After fixation with 4% formaldehyde for 10 min and permeabilization with 0.1% Triton X100 in PBS for another 10 min cells were washed with DPBS and incubated with 50 µM 6 in PBST and with 500 nM DRAQ5 for 15 min. Pictures of fixed cells were taken at 405 nm excitation. Emission was collected at 525-648 nm. DRAQ channel: Exc. 633 nm, Em. 667-748 nm ( Figure S22 ). 
ConA-dTCO Experiment 3
U2OS cells were fixed with 4% formaldehyde for 10 min. After permeabilization with 0.1% Triton X100 in PBS cells and 3x washing with PBS 0.05% TWEEN20 (PBST) cells were incubated for 10 min with ConA-dTCO (100x diluted) in PBST. After washing 3x with PBST cells were incubated with 50 µM 6 in PBST containing 500 nM DRAQ5 for 15 min. Pictures
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of fixed cells were taken at 405 nm or 458 nm excitation. Emission was collected at 525-648 nm. DRAQ5 channel: Exc. 633 nm, Em. 667-748 nm ( Figure S23 ). Figure S23 . Fixed and permeabilized U2OS cell labeling experiment using ConA-dTCO conjugate and triazine 6.
